New drug could help fight against treatment-resistant malaria
Published: 5 November 2024
The breakthrough development is the first to adapt an approach from cancer treatments to tackle malaria. It works by permanently disabling a protein that Plasmodium falciparum, one of the mosquito-borne parasites which spreads malaria, uses to duplicate itself inside the human body. Chemists and bioscientists from UofG led the development of the new drug. In a paper published in the Journal of Medicinal Chemistry, they outline how the treatment could be more effective than current medication.